In patients with chronic obstructive pulmonary disease (COPD), CLA supplementation at a dose of 3.2 g/day for 6 weeks (c9, t11, and c12, t10 isomers in a 50/50 ratio) demonstrated a reduction in serum oxidative stress-related factors, including MDA and matrix metalloproteinase-9 (MMP-9), compared to the placebo group [27], The study suggested that these antioxidant effects were likely a result of the anti-inflammatory properties of CLA, which partly occur through the stimulation of peroxisome proliferator-activated receptors [27]
Satoh A, Imai S-I, Guarente L
Abstract Late-life depression (LLD), a growing public health challenge in aging societies, profoundly impacts physical and mental health by exacerbating cognitive decline, functional disability, and comorbid chronic diseases
The Klow blend, often utilized for its purported benefits related to cellular regeneration, adaptive capacity, and overall systemic balance, provides a robust starting point for diverse research protocols